PATENT CLAIM ANALYSIS

Application Number: 16242922
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["800", "278000"]

Abstract:
The inventive technology relates to systems and methods for enhanced in vivo production, accumulation and modification of cannabinoids. In one embodiment, the invention may include systems and methods for enhanced in vivo biosynthesis of chemically-modified water-soluble cannabinoids in a whole plant, or a cell suspension culture system.

Claim (Index 175):
The method of  claim 164  and further comprising the step of expressing in the genetically modified  Cannabis  plant a nucleotide sequence encoding a myb transcription factor.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 99.0
- Lexical Diversity: 1.40541
- Patent Class: 800.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16110728', '14232465', '14510232', '13641272', '15321585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6202042051988711
- 35 USC 102 Novelty (BERT): 0.6519558767575656
- Combined Prediction Score: 0.6233793723547405
- Mean Citation Score: 478.606618
- Max Citation Score: 893.98035
- Similarity Product: 607.6332371033193

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test